Zimmer Biomet Holdings Inc (ZBH) Position Maintained by Webster Bank N. A.

Webster Bank N. A. held its stake in Zimmer Biomet Holdings Inc (NYSE:ZBH) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,447 shares of the medical equipment provider’s stock at the end of the second quarter. Webster Bank N. A.’s holdings in Zimmer Biomet Holdings were worth $186,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the stock. BlackRock Inc. boosted its position in shares of Zimmer Biomet Holdings by 4,042.4% in the first quarter. BlackRock Inc. now owns 16,740,383 shares of the medical equipment provider’s stock valued at $2,044,168,000 after buying an additional 16,336,262 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Zimmer Biomet Holdings by 3.7% in the first quarter. Vanguard Group Inc. now owns 13,041,411 shares of the medical equipment provider’s stock valued at $1,592,488,000 after buying an additional 464,916 shares in the last quarter. State Street Corp boosted its position in shares of Zimmer Biomet Holdings by 2.4% in the first quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock valued at $1,000,463,000 after buying an additional 191,747 shares in the last quarter. Nordea Investment Management AB boosted its position in shares of Zimmer Biomet Holdings by 25.0% in the first quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock valued at $602,159,000 after buying an additional 987,398 shares in the last quarter. Finally, First Manhattan Co. boosted its position in shares of Zimmer Biomet Holdings by 13.5% in the first quarter. First Manhattan Co. now owns 2,565,370 shares of the medical equipment provider’s stock valued at $333,549,000 after buying an additional 305,668 shares in the last quarter. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Zimmer Biomet Holdings Inc (NYSE:ZBH) traded down 0.93% during trading on Friday, reaching $111.38. The company had a trading volume of 1,036,099 shares. The stock has a market cap of $22.52 billion, a PE ratio of 31.72 and a beta of 1.20. The company has a 50-day moving average price of $122.63 and a 200 day moving average price of $121.15. Zimmer Biomet Holdings Inc has a 52-week low of $95.63 and a 52-week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $2.10 by $0.02. Zimmer Biomet Holdings had a return on equity of 7.31% and a net margin of 9.42%. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.95 billion. During the same quarter in the prior year, the business posted $2.02 earnings per share. Zimmer Biomet Holdings’s revenue was up 1.1% on a year-over-year basis. On average, analysts anticipate that Zimmer Biomet Holdings Inc will post $8.24 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 annualized dividend and a dividend yield of 0.86%. Zimmer Biomet Holdings’s dividend payout ratio is 27.59%.

COPYRIGHT VIOLATION WARNING: This story was reported by BNB Daily and is the property of of BNB Daily. If you are accessing this story on another publication, it was stolen and republished in violation of United States and international trademark & copyright laws. The original version of this story can be accessed at https://www.baseball-news-blog.com/2017/08/19/webster-bank-n-a-holds-stake-in-zimmer-biomet-holdings-inc-zbh-updated-updated-updated.html.

Several equities analysts recently issued reports on the company. Oppenheimer Holdings, Inc. set a $137.00 price objective on Zimmer Biomet Holdings and gave the stock a “buy” rating in a report on Monday, August 14th. Zacks Investment Research cut Zimmer Biomet Holdings from a “hold” rating to a “strong sell” rating in a report on Tuesday, August 8th. BidaskClub cut Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. BMO Capital Markets lifted their price objective on Zimmer Biomet Holdings from $136.00 to $140.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Finally, Leerink Swann lifted their price objective on Zimmer Biomet Holdings from $141.00 to $146.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. Zimmer Biomet Holdings currently has a consensus rating of “Hold” and an average target price of $136.90.

In related news, insider Sang Yi sold 17,731 shares of the stock in a transaction on Monday, June 12th. The stock was sold at an average price of $124.56, for a total transaction of $2,208,573.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Tony W. Collins sold 16,986 shares of the stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The disclosure for this sale can be found here. 1.07% of the stock is currently owned by company insiders.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply